These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8834421)

  • 21. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.
    Cirit M; Toprak O; Yesil M; Bayata S; Postaci N; Pupim L; Esi E
    Nephron Clin Pract; 2006; 104(1):c20-7. PubMed ID: 16685140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE inhibitors. Drug interactions of clinical significance.
    Mignat C; Unger T
    Drug Saf; 1995 May; 12(5):334-47. PubMed ID: 7669262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitor withdrawal and ACE gene polymorphism.
    Nonoguchi H; Kiyama S; Inoue H; Nakayama Y; Inoue T; Kohda Y; Machida K; Tajima A; Kitamura K; Miyoshi T; Shimada H; Shimada H; Tajiri M; Honda Y; Tanaka M; Tomita K
    Clin Nephrol; 2003 Oct; 60(4):225-32. PubMed ID: 14579936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.
    Kurnik D; Vesterman-Landes J; Bialik M; Katzir I; Lomnicky Y; Halkin H; Loebstein R
    Clin Ther; 2011 Apr; 33(4):456-64. PubMed ID: 21635991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum lithium concentration secondary to treatment with tiaprofenic acid and fosinopril.
    Alderman CP; Lindsay KS
    Ann Pharmacother; 1996 Dec; 30(12):1411-3. PubMed ID: 8968454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?
    Reardon LC; Macpherson DS
    Arch Intern Med; 1998 Jan; 158(1):26-32. PubMed ID: 9437375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
    Mathieson L; Severn A; Guthrie B
    Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-Drug Interactions Between Lithium and Cardiovascular as Well as Anti-Inflammatory Drugs.
    Scherf-Clavel M; Treiber S; Deckert J; Unterecker S; Hommers L
    Pharmacopsychiatry; 2020 Sep; 53(5):229-234. PubMed ID: 32340061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diarrhoea, vomiting and ACE inhibitors:--an important cause of acute renal failure.
    Stirling C; Houston J; Robertson S; Boyle J; Allan A; Norrie J; Isles C
    J Hum Hypertens; 2003 Jun; 17(6):419-23. PubMed ID: 12764405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y; Takenaka T; Nakamura T; Suzuki H
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of lithium.
    Jermain DM; Crismon ML; Martin ES
    Clin Pharm; 1991 May; 10(5):376-81. PubMed ID: 2049899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL; Weir MR
    Arch Intern Med; 2000 Mar; 160(5):685-93. PubMed ID: 10724055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
    Kramer HJ
    Z Kardiol; 1988; 77 Suppl 3():39-45. PubMed ID: 3062959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
    Ahmed A; Centor RM; Weaver MT; Perry GJ
    Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics.
    Bucsa C; Moga DC; Farcas A; Mogosan C; Dumitrascu DL
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2938-44. PubMed ID: 26241552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitors in the elderly.
    Reid JL; Macdonald NJ; Lees KR; Elliott HL
    Am Heart J; 1989 Mar; 117(3):751-5. PubMed ID: 2645758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.